Lycopene: A word of caution [2]

American Journal of Health-System Pharmacy

Volumn 62, Issue 9, 2005, Pages 899-

  Ablin, Richard J ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAP JUNCTION PROTEIN; LYCOPENE; UROKINASE;

BONE METASTASIS; CANCER CELL CULTURE; CANCER CYTODIAGNOSIS; CANCER GROWTH; CELL DIFFERENTIATION; CELL GROWTH; DRUG MONITORING; GAP JUNCTION; HUMAN; LETTER; PRECANCER; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; SIDE EFFECT; UPREGULATION;

EID: 17844377588     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/62.9.899     Document Type: Letter

References (3)

1. Everson KM, McQueen CE. Lycopene for prevention and treatment of prostate cancer. Am J Health-Syst Pharm. 2004; 61:1562-6.
2. Wertz K, Siler U, Goralczyk R. Lycopene: modes of action to promote prostate health. Arch Biochem Biophys. 2004; 430:127-34.
3. Forbes K, Gillette K, Sehgal I. Lycopene increases urokinase receptor and fails to inhibit growth or connexin expression in a metastatically passaged prostate cancer cell line: a brief communication. Exp Biol Med (Maywood). 2003; 228:967-71.